Limitations and Remaining Questions While semaglutide has shown significant benefits in reducing joint pain among patients with obesity, several important limitations remain: Studies often lack post-treatment follow-up, making it unclear how durable these pain and weight outcomes are once medication is stopped
Although it has the same active ingredient as Wegovy (semaglutide), Ozempic is primarily approved to control blood sugar levels in adults with type 2 diabetes
Gastrointestinal side effects remain common, titration strategies require patience, and certain patientsespecially those with medullary thyroid carcinoma, severe gastroparesis, or history of pancreatitismay not qualify for therapy
If youre looking for an affordable solution to your weight loss goals I highly recommend Elevate wellness with keepsake Kottage! Amazing customer care at this IV Therapy and weight loss office here in Wichita
See how this online service compares in under 60 seconds | Health On Forbes